Our Impact
When the Global TB Caucus was launched in 2014 there were 5 national parliamentary groups working on TB: Brazil, Canada, Japan, United Kingdom, and the United States. To date, the Caucus has grown rapidly and currently has:
Representation in 150 countries
Representation in 44 countries on the WHO's list of high TB burden countries
Now supports 53 national caucuses worldwide
Expanded to over 2,500 members
Representation in 18 G20 countries
Connected 88 CSOs with MPs in their countries
In 2019
We have seen increased domestic resources mobilised for TB over the past year in 24 of the 48 TB high-burden (HB) countries listed by WHO. Of these 24 countries, 19 (80%) have members from the Caucus and 11 (46%) have National Caucuses.
Seven HB countries are on track to achieve the TB SDGs for 2030: Kenya, Lesotho, Myanmar, Russia, South Africa, Tanzania and Zimbabwe. The Caucus has members in 6 of these countries, and in our biannual analysis of MPs activities, we note that these MPs have consistently taken meaningful and impactful political actions.
Twenty-six countries increased their pledges to the Global Fund compared to the previous cycle, representing USD 12.1 billion. The Global TB Caucus has members in 22 of the 26 countries (84%), and MPs in these countries have consistently taken impactful political actions. 22 countries pledged for the first time, adding USD 226.82 million to the total pledge.
Our Results
New TB legislations
successful G20 advocacy campaign
Unlocked new funding for R&D
In 2019, 24 of the 48 TB high burden countries reported increases in domestic budgets for TB (representing a total increase of over USD 138 million), while 28 reported an increase in the percentage of domestic contribution to the total estimated funding for TB. 19 of the 24 (80%) countries reporting increases have members from the Global TB Caucus and 11 (46%) have active national caucuses. Of these 19, in our biannual analysis of MPs activities, we note that MPs in 12 countries have consistently taken meaningful and impactful political actions.
59 countries made pledges to the Global Fund 2019 replenishment: 42% of them had a National Caucus in place, and 68% have members of the Global TB Caucus. 26 countries increased their pledges in relation to the previous cycle, representing USD 12.1 billion. The Global TB Caucus has members in 22 of the 26 countries (84%), and in our biannual analysis of MPs activities, we note that these MPs have consistently taken meaningful and impactful political actions. 22 countries pledged for the first time since 2013, representing USD 226.82 million. Of these countries, 13 have Global TB Caucus members (56%), and they have MPs who have consistently taken impactful political actions.
Since November 2016, the Caucus has led advocacy efforts around TB and antimicrobial resistance (AMR) to help secure strong language in the G20 Leaders and Health Ministers’ Declarations. This year, the aim was to help ensure that TB stayed firmly on the AMR agenda, and that TB research and development funding was maintained and increased. In October 2019, the final version of the G20 Ministers of Health Declaration was issued, reaffirming commitment to end the epidemics of AIDS, Tuberculosis and Malaria, and to the High-Level Meeting targets. The declaration welcomed the success of the 6th replenishment of the Global Fund and encouraged all countries to strengthen their efforts to achieve the SDG targets.
Since the establishment of the Caucus, members of the network have worked intensively on drafting TB, UHC or health related legislation in their countries. Having specific laws on TB are a useful tool to hold governments accountable on the UNHLM targets and implement them in country, but also to guarantee the respect of TB patients’ human rights. Collaborating with leading human rights and legal experts, the Caucus has been holding TB legislation workshops in its different events and summits, including the Union Conference last October in Hyderabad and the Americas TB Summit in Rio, leading a global movement to legislate on the issue. Today, legislation has been implemented in several Caucus countries, including the Philippines, Peru, Paraguay and Georgia.
Only three countries—the United Kingdom, the Philippines, and South Africa—met their “fair share” targets by spending at least 0.1% of their overall R&D expenditures on TB research. These countries have national caucuses, and in our biannual analysis of MPs activities, we noted that these MPs have consistently taken meaningful and impactful political actions. Of the 14 countries reporting increases in R&D budgets for TB, 11 (79%) have members from the Global TB Caucus and 7 (50%) have active national caucuses. Of these 14, in our biannual analysis of MPs activities, we note that MPs in 10 countries have consistently taken meaningful and impactful political actions. In total, there was an increase of USD112,403,102 between 2017 and 2018 in Caucus countries.